Companies: 10,795·Total market cap: $144.5T
F-star Therapeutics, Inc.

F-star Therapeutics, Inc.

FSTXNASDAQHealthcare
$7.12
+$0.00(+0.00%)
Market Cap$156511128
P/E Ratio
52W High$7.12
52W Low$2.07
Overview

F-star Therapeutics, Inc. (FSTX) · Balance Sheet

Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.

FMP · FSTX · as of 2026-06-10

Financial statements

Total Assets · Total Liabilities · Equity
Breakdown2021-122020-122019-122018-122017-12
Assets
Cash & ST Investments$78.55M$18.53M$4.90M$47.64M$50.55M
Net Receivables$2.31M$4.01M$11.37M$0.00M$0.00M
Inventory($2.31M)$2.77M$2.41M$0.00M$0.00M
Total Current Assets$84.74M$26.07M$19.02M$49.29M$51.13M
PP&E Net$4.17M$3.57M$2.03M$2.32M$0.69M
Goodwill$14.90M$14.93M$4.32M$0.00M$0.00M
Intangible Assets$18.77M$18.99M$13.05M$0.00M$0.00M
Total Assets$123.02M$63.61M$38.48M$68.41M$51.82M
Liabilities
Short-Term Debt$0.91M$0.54M$15.52M$0.00M$0.00M
Accounts Payable$3.08M$4.60M$5.06M$1.88M$1.70M
Total Current Liabilities$12.13M$16.98M$29.89M$4.25M$4.43M
Long-Term Debt$12.33M$2.62M$0.05M$0.00M$0.00M
Total Liabilities$26.16M$20.61M$29.94M$12.95M$17.59M
Stockholders Equity
Retained Earnings($78.45M)($47.17M)($21.55M)($102.07M)($79.21M)
Total Stockholders Equity$96.86M$42.99M$8.54M$55.86M$34.75M
Total Liab & Equity(computed)$123.02M$63.61M$38.48M$68.81M$52.34M
Debt Summary
Total Debt$13.23M$3.16M$15.57M$0.00M$0.00M
Net Debt($65.31M)($15.37M)$10.67M($14.72M)($23.65M)

Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · M

Explore more F-star Therapeutics, Inc. data

About F-star Therapeutics, Inc. (FSTX) Balance Sheet

F-star Therapeutics, Inc. (FSTX) balance sheet shows total assets of $0.12B with cash of $0.08B. Total liabilities are $0.03B, total debt $0.01B, and stockholders equity $0.10B.

Frequently asked questions

FSTX · 4 questions

F-star Therapeutics, Inc. has total debt of $0.01B with net debt of ($0.07B).

FSTX total debtnet debtdebt to equity

· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10